Article Information
History
- July 17, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Sharon K. Greene, PhD*,1,
- Alison Levin-Rector, MPH1,
- Elizabeth Luoma, MPH1,
- Helly Amin, BS3,
- Emily McGibbon, MPH1,
- Robert W. Mathes, MPH1 and
- Shama D. Ahuja, PhD2
- 1Bureau of Communicable Disease, New York City Department of Health and Mental Hygiene, New York City, NY, USA
- 2Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York City, NY, USA
- 3Bureau of the Public Health Laboratory, New York City Department of Health and Mental Hygiene, New York City, NY, USA
- ↵*Corresponding author: sgreene4{at}health.nyc.gov
Posted July 17, 2022.
Assessment of COVID-19 hospitalization risk during SARS-CoV-2 Omicron relative to Delta variant predominance, New York City, August 2021–January 2022
